Cargando…
Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin‐naïve type 2 diabetes
The pharmacokinetics of metformin therapy in patients with chronic kidney disease stage 4 (CKD‐4) were studied using data from the largest Phase I consecutive cohort trial yet performed in this population. Eighteen metformin‐naïve men and women with Type 2 Diabetes and creatinine clearance (CrCl) in...
Autores principales: | Dissanayake, Ajith M., Wheldon, Mark C., Hood, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138239/ https://www.ncbi.nlm.nih.gov/pubmed/30221006 http://dx.doi.org/10.1002/prp2.424 |
Ejemplares similares
-
Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy
por: Dissanayake, Ajith Munasinghe, et al.
Publicado: (2017) -
Metformin improves diabetic kidney disease
por: Beladi Mousavi, Seyed Seifollah, et al.
Publicado: (2012) -
Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
por: Sun, Lin, et al.
Publicado: (2011) -
Pharmacokinetic study of metformin to compare a voglibose/metformin fixed-dose combination with coadministered voglibose and metformin
por: Choi, Hyang-Ki, et al.
Publicado: (2015) -
Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
por: Kim, Dong-Lim
Publicado: (2013)